Martine J. Jager

15.6k citations

311 papers · 9.4k indexed · 3 hit papers · h-index 50

Ophthalmology top 0.02%
Molecular Biology top 2%
Immunology top 0.5%
Oncology top 0.5%
Radiology, Nuclear Medicine and Imaging top 1%

Co-authors: Gregorius P. M. Luyten Pieter A. van der Velden Inge H. G. Bronkhorst Ekaterina S. Jordanova Long V. Ly Mehmet Doğrusöz Willem Maat Nelleke A. Gruis
Topics: Ocular Oncology and Treatments (180 papers)Immunotherapy and Immune Responses (112 papers)Corneal Surgery and Treatments (45 papers)
Cited by: Ophthalmology Immunology Oncology
Journals: Journal of Clinical OncologySHILAP Revista de lepidopterologíaThe Journal of Immunology
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Martine J. Jager

305 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Uveal melanoma

2020 495 citations Martine J. Jager et al. profile →
Advances in the clinical management of uveal melanoma

2023 129 citations Martine J. Jager, J. William Harbour et al. profile →
Current Challenges and Opportunities of Photodynamic Therapy against Cancer

2023 102 citations Martine J. Jager et al. profile →

Peers

Countries citing papers authored by Martine J. Jager

Since Specialization

Citations

This map shows the geographic impact of Martine J. Jager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martine J. Jager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martine J. Jager more than expected).

Fields of papers citing papers by Martine J. Jager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martine J. Jager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martine J. Jager. The network helps show where Martine J. Jager may publish in the future.

Co-authorship network of co-authors of Martine J. Jager

This figure shows the co-authorship network connecting the top 25 collaborators of Martine J. Jager. A scholar is included among the top collaborators of Martine J. Jager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martine J. Jager. Martine J. Jager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Survival in Patients with Uveal Melanoma Is Linked to Genetic Variation at HERC2 Single Nucleotide Polymorphism rs12913832 2024 ·Ophthalmology ·Maria Chiara Gelmi,(unknown),Annemijn P. A. Wierenga,(unknown),Bastiaan T. Heijmans,Gregorius P. M. Luyten,Peter de Knijff,(unknown),Rick H. de Leeuw,Martine J. Jager	0
2	Uveal melanoma: Current evidence on prognosis, treatment and potential developments 2024 ·Asia-Pacific Journal of Ophthalmology ·Maria Chiara Gelmi,Martine J. Jager	14
3	PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma 2023 ·Investigative Ophthalmology & Visual Science ·Maria Chiara Gelmi,Gülçin Gezgin,Pieter A. van der Velden,Gregorius P. M. Luyten,(unknown),Mirjam H.M. Heemskerk,Martine J. Jager	12
4	High C-Reactive Protein Levels Are Related to Better Survival in Patients with Uveal Melanoma 2022 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Annelies de Klein,Dion Paridaens,Robert M. Verdijk,Tos T. J. M. Berendschot,Erwin Brosens,Martine J. Jager,Emine Kılıç	2
5	Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma 2021 ·BMC Cancer ·(unknown),(unknown),Mieke Versluis,Gregorius P. M. Luyten,Robert M. Verdijk,Michele C. Madigan,Martine J. Jager,Pieter A. van der Velden	23
6	In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target 2021 ·Cancers ·(unknown),Annemijn P. A. Wierenga,(unknown),Pieter A. van der Velden,Gregorius P. M. Luyten,Robert M. Verdijk,Martine J. Jager	3
7	Expression of HDACs 1, 3 and 8 Is Upregulated in the Presence of Infiltrating Lymphocytes in Uveal Melanoma 2021 ·Cancers ·(unknown),Aart G. Jochemsen,Annemijn P. A. Wierenga,Wilma G. M. Kroes,Robert M. Verdijk,Pieter A. van der Velden,Gregorius P. M. Luyten,Martine J. Jager	9
8	Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time 2020 ·Ocular Oncology and Pathology ·(unknown),Annemijn P. A. Wierenga,Sjoerd G. van Duinen,Robert M. Verdijk,Jaco C. Bleeker,Marina Marinkovic,Gregorius P. M. Luyten,Martine J. Jager	18
9	Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines 2019 ·Cancers ·Cindy Chau,Remco van Doorn,Natasha M. van Poppelen,Nienke van der Stoep,Arjen R. Mensenkamp,Rolf H. Sijmons,(unknown),Ans M.W. van den Ouweland,Nicole C. Naus,Annemieke H. van der Hout,Thomas P. Potjer,Fonnet E. Bleeker,Marijke R. Wevers,Liselotte P. van Hest,Marjolijn C.J. Jongmans,Marina Marinkovic,Jaco C. Bleeker,Martine J. Jager,Gregorius P. M. Luyten,Maartje Nielsen	39
10	Secondary Somatic Mutations in G-Protein-Related Pathways and Mutation Signatures in Uveal Melanoma 2019 ·Cancers ·Francesca Piaggio,(unknown),Cinzia Bernardi,Michela Croce,Roberto Puzone,Silvia Viaggi,(unknown),Annalisa Barla,Domenico Coviello,Martine J. Jager,Pieter A. van der Velden,Michael Zeschnigk,Davide Cangelosi,Alessandra Eva,Ulrich Pfeffer,Adriana Amaro	22
11	Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma? 2019 ·Cancers ·(unknown),Annemijn P. A. Wierenga,(unknown),Thorbald van Hall,Pieter A. van der Velden,Wilma G. M. Kroes,Ulrich Pfeffer,Gregorius P. M. Luyten,Martine J. Jager	11
12	Neuroinflammation and microglia in glaucoma: time for a paradigm shift 2018 ·Journal of Neuroscience Research ·Xin Wei,Kin‐Sang Cho,Eric F. Thee,Martine J. Jager,Dong Feng Chen	156
13	Digital PCR-Based T-cell Quantification–Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma 2018 ·Molecular Cancer Research ·Mark J. de Lange,(unknown),(unknown),Mieke Versluis,Ekaterina S. Jordanova,Gré P.M. Luyten,Martine J. Jager,Sjoerd H. van der Burg,Willem H. Zoutman,Thorbald van Hall,Pieter A. van der Velden	33
14	PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma 2016 ·Clinical Cancer Research ·Matthew G. Field,Christina L. Decatur,Stefan Kurtenbach,Gülçin Gezgin,Pieter A. van der Velden,Martine J. Jager,(unknown),J. William Harbour	196
15	Uveal Melanoma Cell Lines: Where do they come from? (An American Ophthalmological Society Thesis). 2016 ·PubMed ·Martine J. Jager,(unknown),Bruce R. Ksander,Sander R. Dubovy	73
16	A fish scale-derived scaffold for corneal reconstruction 2013 ·Investigative Ophthalmology & Visual Science ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Gregorius P. M. Luyten,Abdoelwaheb El Ghalbzouri,Martine J. Jager	1
17	Peptide Vaccination after T-Cell Transfer Causes Massive Clonal Expansion, Tumor Eradication, and Manageable Cytokine Storm 2010 ·Cancer Research ·Long V. Ly,Marjolein Sluijter,Mieke Versluis,Gré P.M. Luyten,Sjoerd H. van der Burg,Cornelis J.M. Melief,Martine J. Jager,Thorbald van Hall	40
18	Triamcinolone acetonide and anecortave acetate do not stimulate uveal melanoma cell growth. 2008 ·PubMed ·(unknown),Irene Homminga,Willem Maat,Pieter A. van der Velden,Martine J. Jager	14
19	Expression of epidermal growth factor receptor: risk factor in uveal melanoma. 2000 ·PubMed ·H. M. H. Hurks,(unknown),(unknown),A. H. Zwinderman,D. de Wolff–Rouendaal,J. E. E. Keunen,Martine J. Jager	35
20	Keimemissionen im Umfeld von Kompostierungsanlagen 1996 ·TUbilio (Technical University of Darmstadt) ·(unknown),Martine J. Jager,(unknown)	1

About Martine J. Jager

Martine J. Jager is a scholar working on Ophthalmology, Immunology and Immunology and Allergy, having authored 311 papers that have together received 9.4k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (180 papers), Immunotherapy and Immune Responses (112 papers) and Corneal Surgery and Treatments (45 papers). The work is most often cited by research in Ophthalmology (5.8k citations), Immunology (3.4k citations) and Oncology (2.7k citations). Martine J. Jager has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Gregorius P. M. Luyten, Pieter A. van der Velden, Inge H. G. Bronkhorst, Ekaterina S. Jordanova, Long V. Ly, Mehmet Doğrusöz, Willem Maat, Nelleke A. Gruis, Mieke Versluis and Hans E. Grossniklaus. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact